A Shigella sonnei clone with extensive drug resistance associated with waterborne outbreaks in China.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 36450777.
- Also identified by DOI 10.1038/s41467-022-35136-1 and PMC identifier 9709761.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Antimicrobial resistance of Shigella sonnei has become a global concern. Here, we report a phylogenetic group of S. sonnei with extensive drug resistance, including a combination of multidrug resistance, coresistance to ceftriaxone and azithromycin (cef<sup>R</sup>azi<sup>R</sup>), reduced susceptibility to fluoroquinolones, and even colistin resistance (col<sup>R</sup>). This distinct clone caused six waterborne shigellosis outbreaks in China from 2015 to 2020. We collect 155 outbreak isolates and 152 sporadic isolates. The cef<sup>R</sup>azi<sup>R</sup> isolates, including outbreak strains, are mainly distributed in a distinct clade located in global Lineage III. The outbreak strains form a recently derived monophyletic group that may have emerged circa 2010. The cef<sup>R</sup>azi<sup>R</sup> and col<sup>R</sup> phenotypes are attributed to the acquisition of different plasmids, particularly the IncB/O/K/Z plasmid coharboring the bla<sub>CTX-M-14</sub>, mphA, aac(3)-IId, dfrA17, aadA5, and sul1 genes and the IncI2 plasmid with an mcr-1 gene. Genetic analyses identify 92 accessory genes and 60 single-nucleotide polymorphisms associated with the cef<sup>R</sup>azi<sup>R</sup> phenotype. Surveillance of this clone is required to determine its dissemination and threat to global public health.
Medical subject headings
- Shigella sonnei
- Disease Outbreaks